USC cancer center begins study of early breast cancer blood test
The study will check whether a liquid biopsy, used with mammograms, finds tumors sooner than mammograms do alone.
By Standard Topic. AI-generated from the reporting listed under Coverage. Published . Updated .
This story is no longer being updated. It reflects reporting up to .
What happened
Researchers at USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, have started a study of a blood test for breast cancer. The study will assess whether a liquid biopsy can be used with mammograms to detect the disease earlier than mammograms alone. The blood test may be able to detect breast cancer as early as Stage I.
Why it matters
The aim is earlier detection and treatment of breast cancer than mammograms alone allow.
Coverage
- A Blood Test That Could Detect Breast Cancer as Early as Stage I Has Started Clinical Trials (discovermagazine.com)
- Clinical trial to evaluate blood test for early detection of breast cancer (news.keckmedicine.org)
More from Health
- Hackensack Meridian Health and Hunterdon Health agree to merge
- Roche signs $15 billion antibody-drug conjugate deal with Hansoh
- Putin's daughter predicts aging breakthroughs within 10 to 20 years
- Cardiologists urged to prescribe exercise for heart patients
- Pennsylvania measles outbreak tops 1,200 as CDC sends investigator
- AstraZeneca enlists Oracle to apply AI in drug trials